Journal of Medicine and Life Science

  • 제15권1호
  • /
  • Pages.6-11
  • /
  • 2018
  • /
  • 1738-1010(pISSN)
  • /
  • 2671-4922(eISSN)
제주대학교 의과학연구소 (Institute for Medical Science)
권호 표지
DOI QR코드

DOI QR Code

감귤 내 생리활성성분이 간암세포의 생존에 미치는 영향

Effect of active ingredients in the Citrus fruits on the proliferation of hepatocellular carcinoma cells

  • 김수정 (제주대학교 의학전문대학원 의학과) ;
  • 박덕배 (제주대학교 의학전문대학원 조직학교실)
  • Kim, Soo Jung (Department of Medicine, Jeju National University School of Medicine) ;
  • Park, Deok Bae (Laboratory of Histology, Jeju National University School of Medicine)
  • 투고 : 2018.05.31
  • 심사 : 2018.06.12
  • 발행 : 2018.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Previous studies have suggested that Citrus fruits might suppress the proliferation of various cancer cells. However, little is known about any specific ingredients in the extract of Citrus fruits to exert its anti-proliferative activity in cancer cells. The present study aimed to identify the active ingredients in Citrus fruits to suppress the proliferation of rat hepatocellular carcinoma cells. Among tested compounds, two polymethoxylated flavones (nobiletin and tangeritin) showed significant anti-proliferative activity whereas other compounds (synephrine, rutin, hesperidin) did not. Interestingly, nobiletin as well as tangeritin also decreased the protein amount of gluconeogenic enzymes, PEPCK and G6Pase. The possible involvement of gluconeogenic activity in the proliferation of hepatocellulacarcinoma cells are further to be investigated.

키워드

참고문헌

  1. Santa C, Alessandro M, Nadia F, Sebastiano G, Gioacchino, Udo S, et al. Anticancer Potential of Citrus Juices and Their Extracts: A Systematic Review of Both Preclinical and Clinical Studies. Front Pharmacol 2017;8:420. https://doi.org/10.3389/fphar.2017.00420
  2. Ravishankar D, Rajora AK, Greco F, Osborn HM. Flavonoids as prospective compounds for anti-cancer therapy. Int J Biochem Cell Biol 2013;45:2821-31. https://doi.org/10.1016/j.biocel.2013.10.004
  3. Kozlowska A, Szostak-Wegierek D. Flavonoids-food sources and health benefits. Rocz Panstw Zakl Hig 2014;65:79-85.
  4. Clere N, Faure S, Martinez MC, Andriantsitohaina R. Anticancer properties of flavonoids: roles in various stages of carcinogenesis. Cardiovasc Hematol Agents Med Chem 2011;9:62-77. https://doi.org/10.2174/187152511796196498
  5. Choi EJ. Hesperetin induced G1-phase cell cycle arrest in human breast cancer MCF-7 cells: involvement of CDK4 and p21. Nutrition and Cancer 2007;59:115-9. https://doi.org/10.1080/01635580701419030
  6. Li H, Yang B, Huang J, Xiang T, Yin X, Wan J, Luo F, Zhang L, Li H, Ren G, Huang YJ. Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting beta-catenin signaling pathway. Toxicol Lett 2013;220:219-28. https://doi.org/10.1016/j.toxlet.2013.05.006
  7. Morley KL, Ferguson PJ, Koropatnick J. Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells. Cancer Lett 2007;251:168-78. https://doi.org/10.1016/j.canlet.2006.11.016
  8. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5. https://doi.org/10.1038/227680a0
  9. Harmelin MB, Anavi S, Madar Z, Tirosh O. Fatty acids-stress attenuates gluconeogenesis induction and glucose production in primary hepatocytes. Lipids Health Dis 2012;11:66. https://doi.org/10.1186/1476-511X-11-66
  10. Yukihiro A, Ryo H, Hiroshi H, Kazuhisa S. Use of silkworms for identification of drug candidates having appropriate pharmacokinetics from plant sources. BMC Pharmacol 2010;10:7.
  11. Carrington J, Morwood ML. The Citrus Flavone Nobiletin Reduces Pro-Inflammatory and Pro-Labour Mediators in Fetal Membranes and Myometrium: Implications for Preterm Birth. PLoS One 2014;9(9):e108390. https://doi.org/10.1371/journal.pone.0108390
  12. Santa C, Nadia F, Giovanni E, Lombardo AM, Gioacchino C, Sebastiano G, et al. Chemopreventive Agents and Inhibitors of Cancer Hallmarks: May Citrus Offer New Perspectives? Nutrients 2016;8(11):698. https://doi.org/10.3390/nu8110698
  13. Jianchu C, Ashley C, Allen YC, Haizhi H, Zhaoliang L, Gary OR, et al. Nobiletin suppresses cell viability through AKT Pathways in PC-3 and DU-145 prostate cancer cells. BMC Pharmacol Toxicol 2014;15:59. https://doi.org/10.1186/2050-6511-15-59
  14. Cheng HL, Hsieh MJ, Yang JS, Lin CW, Lue KH, Lu KH, et al. Nobiletin inhibits human osteosarcoma cells metastasis by blocking ERK and JNK-mediated MMPs expression. Oncotarget 2016;7(23):35208-23.
  15. Hirano T, Abe K, Gotoh M, Oka K. Citrus flavone tangeretin inhibits leukaemic HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes. Br J Cancer 1995;72(6):1380-8. https://doi.org/10.1038/bjc.1995.518
  16. Arafa EA, Zhu Q, Barakat BM, Wani G, Zhao Q, El-Mahdy MA, et al. Tangeretin Sensitizes Cisplatin-resistant Human Ovarian Cancer Cells through Down-regulation of PI3K/Akt Signaling Pathway. Cancer Res 2009;69(23):8910-7. https://doi.org/10.1158/0008-5472.CAN-09-1543
  17. Yuk T, Kim Y, Yang J, Sung J, Jeong HS, Lee J. Nobiletin Inhibits Hepatic Lipogenesis via Activation of AMP-Activated Protein Kinase. Evid Based Complement Alternat Med 2018;2018:7420265.
  18. Hardie DG, Ross FA, Hawley SA. AMPK-a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 2012;13(4):251-62.
  19. Zheng Z, Zhu W, Yang B, Chai R, Liu T, Li F, et al. The co-treatment of metformin with flavone synergistically induces apoptosis through inhibition of PI3K/AKT pathway in breast cancer cells. Oncol Lett 2018;15(4):5952-8.